Gonzalez Hemil, Podany Anthony, Al-Harthi Lena, Wallace Jennillee
Department of Internal Medicine, Division of Infectious Disease, Rush University Medical Center, Chicago, IL, USA.
Department of Microbial Pathogens and Immunity, Rush University Medical Center, Chicago, IL, USA.
J Neuroimmune Pharmacol. 2021 Mar;16(1):144-158. doi: 10.1007/s11481-020-09907-w. Epub 2020 Mar 9.
Following the introduction of combination antiretroviral therapy (cART), the morbidity and mortality from human immunodeficiency virus (HIV) infection has been drastically curtailed and HIV has now become a chronic manageable disease. Persons living with HIV (PLWH) are living longer and experiencing significant co-morbidities and conditions of aging. NeuroHIV, clinically defined as HIV-Associated Neurocognitive Disorders (HAND) and pathologically manifested by persistent inflammation in the CNS despite cART, is a significant co-morbid condition for PLWH. In the pre-cART era, HIV mediated much of the pathogenesis in the Central Nervous System (CNS); in the cART era, with low to undetectable viremia, other mechanisms may be contributing to persistent neuroinflammation. Emerging data point to the adverse effects at the cellular level of cART, independent of HIV. Astrocytes are the most abundant cells in the CNS, playing vital roles in maintaining CNS homeostasis (e.g. metabolic support to neurons, clearance of neurotransmitters, ion balance, modulation of synaptic functions and maintaining the structural integrity of the blood brain barrier (BBB). Therefore, any disruption of their function will have wide repercussions in the CNS. In this review, we will address current knowledge and gaps on the impact of antiretrovirals (ARVs) on astrocytes and physiologic consequences in the CNS. Understanding the status of this field, will provide a practical framework to elucidate the potential role of cART-mediated dysregulation of astrocytes in neuroHIV pathogenesis and inform therapeutic strategies that are "neuro-friendly". Graphical abstract CNS-penetrating cART have the potential to cause resting astrocytes to become activated into an A1 or neurotoxic phenotype. These cells can in turn secrete inflammatory cytokines that affect surrounding microglia macrophages, as well as neurotoxic factors that impact nearby neurons. In addition, impairment in the physiologic functions of astrocytes will result in altered BBB permeability and disrupted metabolic homeostasis. CNS=Central Nervous System; cART=combined antiretroviral therapy; BBB=blood brain barrier.
随着联合抗逆转录病毒疗法(cART)的引入,人类免疫缺陷病毒(HIV)感染导致的发病率和死亡率已大幅降低,HIV现在已成为一种可慢性控制的疾病。HIV感染者(PLWH)的寿命延长,同时出现了显著的合并症和衰老相关状况。神经HIV在临床上被定义为HIV相关神经认知障碍(HAND),尽管接受了cART,但在病理上表现为中枢神经系统(CNS)的持续炎症,是PLWH的一种重要合并症。在cART前时代,HIV介导了中枢神经系统的大部分发病机制;在cART时代,病毒血症水平低至无法检测,其他机制可能导致持续的神经炎症。新出现的数据表明,cART在细胞水平上存在独立于HIV的不良反应。星形胶质细胞是中枢神经系统中数量最多的细胞,在维持中枢神经系统稳态方面发挥着至关重要的作用(例如为神经元提供代谢支持、清除神经递质、维持离子平衡、调节突触功能以及维持血脑屏障(BBB)的结构完整性)。因此,其功能的任何破坏都会在中枢神经系统中产生广泛影响。在本综述中,我们将阐述关于抗逆转录病毒药物(ARVs)对星形胶质细胞的影响以及中枢神经系统生理后果的现有知识和空白。了解该领域的现状,将提供一个实用框架,以阐明cART介导的星形胶质细胞失调在神经HIV发病机制中的潜在作用,并为“神经友好型”治疗策略提供依据。图形摘要 可穿透中枢神经系统的cART有可能使静息星形胶质细胞激活为A1或神经毒性表型。这些细胞反过来可分泌影响周围小胶质细胞巨噬细胞的炎性细胞因子,以及影响附近神经元的神经毒性因子。此外,星形胶质细胞生理功能的损害将导致血脑屏障通透性改变和代谢稳态破坏。CNS=中枢神经系统;cART=联合抗逆转录病毒疗法;BBB=血脑屏障